Denise Scots-Knight

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Christine Fox, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Denise Scots-Knight:

Company Role Class Num Shares Value Price $ Report Date Ownership
Elanco Animal Health Inc Director Common Stock 88,714 $1,996,065 $22.50 28 Nov 2025 Direct
Mereo BioPharma Group plc Chief Executive Officer, Director Share Options (Right to buy) 480,000 $833,250 $1.01 01 Feb 2026 Direct

Insider Reports Filed by Denise Scots-Knight

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MREO Mereo BioPharma Group plc 01 Feb 2026 3 $0 4 Chief Executive Officer, Director 02 Feb 2026, 16:30
ELAN Elanco Animal Health Inc 28 Nov 2025 1 $0 4 Director 02 Dec 2025, 17:10
MREO Mereo BioPharma Group plc 25 Jan 2025 1 $0 4 Chief Executive Officer 28 Jan 2025, 16:05
ELAN Elanco Animal Health Inc 29 Nov 2024 1 $0 4 Director 03 Dec 2024, 17:10
MREO Mereo BioPharma Group plc 12 Sep 2024 2 -$381,423 4 Chief Executive Officer, Director 16 Sep 2024, 20:50
MREO Mereo BioPharma Group plc 11 Sep 2024 2 $0 4 Chief Executive Officer, Director 13 Sep 2024, 16:49
MREO Mereo BioPharma Group plc 25 Jun 2024 2 -$463,487 4 Chief Executive Officer, Director 27 Jun 2024, 16:15
MREO Mereo BioPharma Group plc 21 Jun 2024 2 $0 4 Chief Executive Officer, Director 25 Jun 2024, 18:15
MREO Mereo BioPharma Group plc 25 Jan 2024 1 $0 4 Chief Executive Officer 26 Jan 2024, 16:15
MREO Mereo Biopharma Group plc 01 Jan 2024 0 $0 3 Chief Executive Officer 02 Jan 2024, 16:15
ELAN Elanco Animal Health Inc 30 Nov 2023 1 $0 4 Director 04 Dec 2023, 17:32
ELAN Elanco Animal Health Inc 30 Nov 2022 1 $0 4 Director 02 Dec 2022, 16:07
ELAN Elanco Animal Health Inc 30 Nov 2021 1 $0 4 Director 02 Dec 2021, 16:08